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Membrane proteins are involved in a wide variety of cellular processes, and are typically part of the first
interaction a cell has with extracellular molecules. As a result, these proteins comprise a majority of known
drug targets. Membrane proteins are among the most difficult proteins to obtain and characterize, and
a structure-based understanding of their properties can be difficult to elucidate. Notwithstanding, the design
ofmembrane proteins can provide stringent tests of our understanding of these crucial biological systems, as
well as introduce novel or targeted functionalities. Computational design methods have been particularly
helpful in addressing these issues, and this review discusses recent studies that tailor membrane proteins
to display specific structures or functions and examines how redesigned membrane proteins are being
used to facilitate structural and functional studies.Introduction
Residing within lipid bilayers, integral membrane proteins are
ubiquitous in cells, and it is estimated that roughly 15–30% of
the proteins in currently known genomes are integral membrane
proteins (Almen et al., 2009; Wallin and von Heijne, 1998). These
proteins participate in a wide diversity of cellular processes,
including selective molecular transport across the bilayer,
uptake of nutrients, discharge of toxins and waste products,
respiration, cell motility, and cell signaling. Given their relevance
to cellular physiology, membrane proteins–particularly receptor
proteins and ion channels–are of great significance for a wide
variety of therapeutics, with 60% of currently available drugs
having a membrane protein as a target (Overington et al.,
2006). In recent years, advances in their study and characteriza-
tion have furthered our understanding of the general molecular
properties and biophysical principles germane to membrane
proteins, but additional work needs to be done to acquire
a detailed, predictive knowledge of the molecular basis of their
structures, stabilities, and activities (White, 2009).
In this brief review, we highlight advances toward the design
and redesign of integral membrane proteins, with special
emphasis on recent applications of computational methods.
The development of approaches to engineer membrane proteins
has exploited advances involving both experimental and com-
putational techniques. After briefly introducing some of themajor
challenges in working with membrane proteins and recent
advances to address these, examples of designed membrane
proteins are presented. Such designs can be used to explore
membrane protein structure, introduce new functionality, modu-
late membrane integrity, control the activity of receptors and
integrins, and arrive at water-soluble variants of membrane
proteins. We focus on cases where designed proteins have
been characterized experimentally.
Challenges in Working with Membrane Proteins
Membrane proteins are notoriously difficult to study in their
natural forms and are often difficult to obtain in large quantity.
Typically present in low amounts in native tissues, these
proteins are difficult to isolate in quantities sufficient for
detailed characterization. The situation is rendered even moreStruchallenging due to the fact that they are also difficult to overex-
press. Given that structural studies of proteins (e.g., using
diffraction-quality crystals or NMR methods) typically require
large amounts (>10 mg) of protein, it is clear that the naturally
low abundance of membrane proteins in their native sources
poses a significant impediment to examining them in detail.
Consequently, most membrane proteins are overexpressed in
heterologous bacterial and eukaryotic expression systems,
a process with its own obstacles. Recombinant production
and/or purification of membrane proteins present major hurdles
in their study and structure determination. In this respect,
eukaryotic recombinant proteins are particularly problematic,
and mammalian membrane proteins are some of the most
challenging. As a result, most membrane protein structures
determined thus far are from bacteria and archaea (Alguel
et al., 2010; Bill et al., 2011).
Even when sufficiently large amounts of protein can be ob-
tained and purified, determining the structures of membrane
proteins can be arduous. These proteins typically have low
stability in the detergents used for dispersion in aqueous media
and are susceptible to aggregation. Obtaining conditions under
which such proteins can be crystallized or studied using NMR
methods can be delicate and time-intensive, often involving
extensive trial and error. Particulary elusive is obtaining quality
crystals suitable for high-resolution X-ray diffraction studies
(Alguel et al., 2010; Bill et al., 2011). Despite these difficulties,
a significant number of membrane protein structures have
been determined over the past 25 years. The number of nonre-
dundant structures is currently around 300 (see (White, 2009)
and the associated online database), which is only about 2%
of known protein structures (Arinaminpathy et al., 2009). Of
note, many of these membrane protein structures have been
realized as protein mutants and chimeras (Chien et al., 2010;
Jaakola et al., 2008; Rasmussen et al., 2011; Rosenbaum
et al., 2007; Shimamura et al., 2011).
Significant progress in preparing membrane protein samples
for structural and functional studies has been made in recent
years. Novel approaches have been developed for improving
the stability of membrane proteins and have facilitated determi-
nation of their structures. Rapid screening assays have beencture 20, January 11, 2012 ª2012 Elsevier Ltd All rights reserved 5
used to optimize the conditions that confer stability using GFP
fusion proteins (Drew et al., 2008; Newstead et al., 2007).
Complexes involving membrane proteins and monoclonal anti-
body fragments can increase the effective surface area and
introduce additional sites for crystal contact formation (Dutzler
et al., 2003; Hunte et al., 2000; Iwata et al., 1995; Rasmussen
et al., 2007; Zhou et al., 2001). Engineered fusion proteins have
also been used in structure determination; for example, a break-
through in the structural biology of G protein-coupled receptors
(GPCRs) came when a chimera was created that included a
robust, crystal-forming protein (T4 lysozyme) and a GPCR, the
human b2 adrenergic receptor (b2-AR; (Cherezov et al., 2007;
Rosenbaum et al., 2007)), resulting in a high-resolution b2-AR
structure. Short-chain detergents can form small micelles that
leave large hydrophilic regions exposed. These detergents can
be used in combination with thermostabilization strategies,
where alanine scanning allows identification of stabilizing muta-
tions so as to make the protein/micelle complex stable enough
for crystallization (Lebon et al., 2011a; Lebon et al., 2011b; Mag-
nani et al., 2008; Serrano-Vega et al., 2008; Shibata et al., 2009;
Warne et al., 2008). The development of improved detergents
has yielded stable protein-detergentmicelles suitable for crystal-
lization (Popot et al., 2003; Yu et al., 2000). Though not specific to
membrane proteins, improvements in robotic technologies
enhance both the exploration of a large number of crystallization
conditions and the collection of the X-ray diffraction data. In
addition, microfocus X-ray diffraction has the promise to reduce
the necessary size of crystals required for solving structures as
well as the ability to examine different regions of the same
crystal, which may have different diffraction qualities (Bowler
et al., 2010).
Design of Membrane Proteins
Structural and functional studies of nature’s membrane proteins
are frontier areas of structural biology, and a variety of beautiful
structures have recently been elucidated. These include GPCRs
(Chien et al., 2010; Jaakola et al., 2008; Palczewski et al., 2000;
Rasmussen et al., 2011; Rosenbaum et al., 2007; Shimamura
et al., 2011; Warne et al., 2008; Wu et al., 2010) and pentameric
ligand-gated ion channels (Bocquet et al., 2009; Hibbs and
Gouaux, 2011; Hilf and Dutzler, 2008, 2009; Miyazawa et al.,
2003). The natural systems are often highly complex, however,
and it is desirable to create systems where the details of function
and structure are more readily at the control of the researcher.
Designing and redesigning membrane proteins is one such route
to better understand and engineer the structure and function
of membrane proteins. Such design endeavors also provide a
way to test hypotheses concerning structure, function, and
protein-protein interactions within membranes. Successful
design can lead to proteins that have new or tunable properties
while residing in the membrane and facilitate studies of their
function and structure. Indeed, many of the recent structures
of eukaryotic integral membrane proteins are mutants and/or
chimeric constructs, where domains have been deleted or exog-
enous domains have been added, so as to render proteins that
are more readily overexpressed, more soluble, or more likely to
crystallize (Chien et al., 2010; Jaakola et al., 2008; Rasmussen
et al., 2011; Rosenbaum et al., 2007; Shimamura et al., 2011;
Wu et al., 2010).6 Structure 20, January 11, 2012 ª2012 Elsevier Ltd All rights reserveEarly successful efforts in membrane protein design focused
on hydrophobic patterning of exterior residues in a manner
consistent with a lipid bilayer. Synthetic a-helical amphiphilic
peptides were designed to mimic properties of protein ion
channels. Comprising only leucine and serine residues, a self-
assembling 21-residue model peptide was designed to span
the membrane and form an ion channel (Lear et al., 1988). The
designed oligomeric protein had properties similar to those of
the acetylcholine receptor with regard to its channel conduc-
tance, cation selectivity, and open-state lifetime (Lear et al.,
1988). An alternative peptide with one heptad position changed
from serine to leucine produced a proton-selective channel,
while a shortened version with only 14 residues was too short
to span the phospolipid bilayer and failed to form discrete stable
channels (Lear et al., 1988). Another early success employed
one, two, and four hydrophobic transmembrane segments.
Using a highly simplified amino acid composition (mainly
leucines and alanines), sequences of the a-helical segments
were tailored for efficient insertion into the inner membrane
when expressed in E. coli. The appropriate positioning of posi-
tively charged lysine residues was found to control the overall
orientation of the protein in the lipid bilayer (Whitley et al., 1994).
Redesigned water-soluble proteins often provide a starting
point for understanding the association of proteins in membrane
environments. An early model system for studying the associa-
tion of coiled-coils in aqueous media was the dimeric leucine
zipper from a eukaryotic transcriptional regulator protein,
GCN4 (Harbury et al., 1993). This system contains buried
asparagine residues that mediate dimerization. The identities
of surface-exposed residues of the dimer were changed from
polar to apolar to create membrane-soluble versions (Choma
et al., 2000; Zhou et al., 2000). In themembrane-soluble analogs,
the same buried asparagines mediate the formation of dimers
and trimers; mutation of the buried asparagines to valines
eliminated oligomerization. The oligomeric equilibrium was
modulated by modification of the relative detergent concentra-
tion, and trimer formation was predominant at the highest
peptide/detergent ratios (Choma et al., 2000). Using similar
analogs, the roles of different residues at the ‘‘a’’ positions
(where ‘‘a’’ is the first position in the heptad repeat of the
coiled-coil structures) along the dimer interface were investi-
gated with regard to their impact on dimer stability (Zhang
et al., 2009). The results reveal that the size and hydrophobic
character of the side chain regulates helix association. The
helix association propensity of amino acids can be rank ordered
Gly > Ala > Val > Ile. This ranking is reversed relative to that ob-
served for dimerization in water-soluble structures (Acharya
et al., 2006; Wagschal et al., 1999). These findings suggest
that van der Waals and electrostatic interactions dominate the
stability and orientational preferences of the intramembrane
dimers.
The approaches described in this section used largely empir-
ical knowledge of structure, sequence, and natural proteins
to create novel membrane proteins. The work has revealed
the degree to which knowledge acquired from studies of glob-
ular proteins can be extended to membrane proteins. Such
studies also reveal features and trends that are unique to
membrane associated proteins. Protein design provides a route
to probe and characterize the biophysical principles governingd
Figure 1. Pentameric Ligand-Gated Ion Channel Chimera
Rendering of the chimera membrane protein structure based on the structure
of GLIC (Protein Data Bank [PDB] accession code: 3EHZ). The extracellular
domain (yellow) is from the prokaryotic proton-gated ion channel GLIC and the
transmembrane domain (blue) is from eukaryotic anionic-selective a1 glycine
receptor (Duret et al., 2011). Small modifications at the interface of the two
domains are colored in magenta and orange. For clarity, the other subunits are
colored gray.protein-protein and protein-lipid interactions in membranes and
opens the potential for more detailed, challenging, and sophisti-
cated designs.
Design of Functional Membrane Proteins
Leveraging the insight gained from studies of transmembrane
helical peptides and proteins, functionality can be introduced
into designed systems. Membrane-associated proteins have
been designed to provide a ‘‘switch’’ that can be used to modu-
late the integrity of a lipid bilayer. In particular, amphiphilic
a-helical peptides are known to be antimicrobial and to rupture
cell membranes. In this regard, mastoparan X, a natural a-helical
cell-lytic peptide has been redesigned to bind divalent cations.
Upon binding of Zn(II) or Ni(II), the amphiphilic structure of the
designed peptide is stabilized, which triggers the lysis of cells
and vesicles (Signarvic and Degrado, 2009). The strategy demo-Strustrates the feasibility of designing proteins that can be selectively
triggered to disrupt membranes.
Fusion of protein domains can yield chimeras that are useful
for structural studies and can also be used to realize designed
membrane proteins with targeted functionalities. One such effort
yielded a pentameric ligand-gated ion channel, where each
subunit comprised a prokaryotic extracellular domain and a
eukaryotic transmembrane domain (Duret et al., 2011). The
extracellular segment of the chimera was the proton-gated
ion channel from Gloeobacter violaceus (GLIC), while the trans-
membrane segment was the anion-selective human a1 glycine
receptor (Figure 1). Putative mismatches at the interface
between the prokaryotic and eukaryotic domains of the chimera
were minimized. The site of fusion was carefully selected and
specific interfacial motifs were switched from the extracellular
identity (GLIC) to the transmembrane identity (a1 glycine
receptor). The chimera functions as a proton-gated ion channel,
as evidenced from electrophysiological data obtained in
Xenopus oocytes. Moreover, using patch-clamp experiments
in baby hamster kidney (BHK) cells it was shown that the chimera
displays anion selectivity identical to that of the glycine receptor.
The activity of the chimera does not require posttranslational
modifications typical of eukaryotic extracellular domains, and
therefore, the protein is a good candidate for bacterial expres-
sion systems. This work provides a starting point for studies of
the coupling between ligand gating and ion channel activity, as
well as drug development; the findings suggest that GLIC and
a1 glycine receptors may possess highly similar structures.
Another example of creating functional membrane proteins
was based on a natural transmembrane dimer motif. Using
the structure of the transmembrane region of glycophorin A, a
bis-histidine binding site was designed to bind the cofactor
Fe-protoporphyrin IX (Cordova et al., 2007). Five out of 32 trans-
membrane residues were modified, and the resulting structure
was characterized in dodecylphosphocholine (DPC) micelles
(Figure 2). The protein binds the cofactor with submicromolar
affinity and retains the dimeric oligomerization state. Moreover,
the catalytic activity of the complex was characterized by the
oxidation of the organic substrate TMB (2,20,5,50-tetramethyl-
benzidine). TMB undergoes two successive oxidations in the
presence of peroxide to produce TMB-ox, and formation of the
latter indicated that the complex presents modest peroxidase
activity. A single mutation (G25F) was introduced to assess
aromatic-porphyrin interactions. The mutant binds heme with a
lower dissociation constant (by a factor of 1/10), displays a
change in the midpoint potential, and presents a decrease in
peroxidase activity. The changes were ascribed to the stabiliza-
tion of the Fe(III) form in themutant. The findings illustrate the use
of designed proteins to control the properties of the porphyrin
cofactor within a membrane-localized environment.
Computational Design of Membrane Proteins
The design efforts described thus far draw heavily upon struc-
tures and sequences derived from natural membrane proteins
and/or qualitative and coarse-grained representations of pro-
tein sequence and structure (e.g., hydrophobic patterning). The
interactions within a structured protein can have many levels
of complexity, and often, more molecular detail is required to
specify structure and activity. Atomistic approaches to designcture 20, January 11, 2012 ª2012 Elsevier Ltd All rights reserved 7
Figure 2. Structure of the Redesigned Glycophorin A in Complex
with the Cofactor Protoporphyrin IX
The designed bis-histidine binding site is depicted together with the proto-
porphyrin IX ligand (Cordova et al., 2007). The modified positions in the
structure of glycophorin A are colored in blue.are potentially more powerful and versatile, particularly when
large numbers of candidate sequences are possible. Nature
uses variation of sequence and selection to arrive at proteins
with precisely tuned structures and functionalities. In the labora-
tory, well-folded proteins can potentially be identified through
the careful choice of sequences, but this choice can be
nontrivial. Proteins contain tens to thousands of amino acid
residues, and even for a single sequence, many conformations
of the backbone are possible. Even if we consider just a single
backbone tertiary structure, exponentially large numbers of
side-chain conformations are possible. In addition, the folded
states of proteins are stabilized largely by noncovalent forces:
van der Waals, hydrophobic, electrostatic, and hydrogen-
bonding interactions. Given the subtlety of these interactions,
reliable estimates of stability with respect to unfolding can be
difficult to calculate usingmolecular modeling methods. Further-
more, the large numbers of potential sequences can lead to8 Structure 20, January 11, 2012 ª2012 Elsevier Ltd All rights reservecombinatorial complexity in protein design: using just the 20
naturally occurring amino acids, a small protein of only 100
amino acids has more than 10130 possible sequences.
To address many of these difficulties, computational methods
have been developed for the design of proteins. Most methods
take as input a target structure, which can be a natural one or
one created de novo via computational modeling. Energy-based
objective functions are used to quantify interactions within
a given structure and assess the compatibility between potential
sequences and targeted structures and functions. The methods
can identify individual sequences or the properties of sequences
in an ensemble likely to possess targeted structural and func-
tional properties (Butterfoss and Kuhlman, 2006; Kang and
Saven, 2007; Samish et al., 2011; Saven, 2011). Optimization-
based methods for identifying such low-energy sequences
employ algorithms such as pruning methods (dead-end elimina-
tion) (Dahiyat and Mayo, 1997; Desmet et al., 1992), Monte Carlo
simulated annealing (Shakhnovich and Gutin, 1993) (Hellinga
and Richards, 1994; Kuhlman and Baker, 2000), and genetic
algorithms (Desjarlais and Handel, 1995). Such methods identify
low-energy sequences. Alternatively, probabilistic methods
characterize an ensemble of sequences and use methods
derived from statistical thermodynamics to estimate the site-
specific probabilities of the amino acids at variable sites within
the protein (Calhoun et al., 2003; Kono and Saven, 2001; Park
et al., 2005; Samish et al., 2011; Yang and Saven, 2005). Compu-
tational protein design may be used to design novel nonbiolog-
ical protein-based molecular systems, to better understand
protein stability and folding, and to facilitate the study of natural
proteins.
The computational design of water-soluble proteins has seen
significant progress (Nanda and Koder, 2010; Samish et al.,
2011; Saven, 2011) and has been extended to the design of
membrane proteins recently. Many of the biophysical principles
involved in protein/protein and protein/membrane interactions
within the anisotropic environment of the lipid bilayer are at
least partially understood. Leveraging this understanding, par-
ticularly with the assistance of computational design methods,
stands to open new routes to the design and investigation of
membrane proteins. Excellent related reviews of membrane
protein design have also recently appeared (Ghirlanda, 2009;
Senes, 2011).
In applying computational protein design, the features and
structures that are specific to membrane proteins must be
identified and quantified. Though they often have well-packed
hydrophobic interiors, membrane proteins also have features
that are distinct from water-soluble proteins. Efforts have been
made to discern and characterize transmembrane helix-helix
interaction motifs (Walters and DeGrado, 2006). Energy func-
tions have been developed based upon the observed frequen-
cies with which the amino acids reside in particular regions
of the lipid bilayer, and these depth-dependent propensities
have been parameterized so as to reproduce the observed
positioning of amino acids in helical transmembrane proteins
(Senes et al., 2007). Relevant to membrane protein design is
work involving the modeling and computational analysis of
membrane protein structures, particularly with an eye toward
structure prediction (Barth et al., 2007). Adjustments to energy
functions developed for soluble proteins have been performedd
Figure 3. Topology of the De Novo Designed
Membrane Protein PRIME
The de novo designed membrane protein PRIME is de-
picted with two nonbiological iron diphenylporphyrin
(FeIIIDPP) cofactors (blue) (Korendovych et al., 2010). The
cofactor binding site is displayed in more detail showing
the axial interaction of the histidine residue and the iron
metal. The second-shell hydrogen bond with threonine
residue is also indicated.using a set of 18 high-resolution crystal structures of membrane
proteins (Barth et al., 2007). Features frequently observed in
membrane proteins were included explicitly: a membrane
depth-dependent term for the amino acids and a bifurcated
hydrogen-bond term in which a carbonyl oxygen accepts more
than one hydrogen bond. Furthermore, a weak Ca-H hydrogen
bond with a carbonyl group was also considered. Such Ca-H
interactions have been observed in transmembrane helices
and suggested to stabilize helix-helix interactions (Bowie,
2011; Senes et al., 2001). The results obtained using proteins
of <150 residues displayed an accuracy of structure prediction
quantified by an RMSD of <2.5 A˚ when the model is compared
to the known crystal structure (Barth et al., 2007). The method
was extended to larger proteins (ranging between 190 and 300
residues) with the addition of experimental constraints on the
structure (Barth et al., 2009). The constraints were extracted
mainly from helix-helix packing arrangements, from a library of
79 high-resolution membrane proteins, cofactor vicinity geome-
tries, and mutagenesis information.
Computational de novo protein design has been used to
explore the residues involved in dimerization of GPCRs. Compu-
tational methods were used to identify three to five mutations at
the putative dimer interface of rhodopsin. The predicted effects
of mutations on the oligomerization state were consistent with
experimentally derived mutation and alanine scanning data.
The results suggest computational design can provide powerful
tools for exploring the role of oligomerization in these important
receptor proteins (Taylor et al., 2008).
Water-soluble proteins have been designed to selectively
bind nonbiological porphyrin-based cofactors (Bender et al.,Structure 20, January2007; Cochran et al., 2005; Fry et al., 2010;
McAllister et al., 2008), and one of these
complexes has been redesigned to yield
a redox-active membrane protein (Korendo-
vych et al., 2010). This membrane protein
(PRIME) was designed to form an antiparallel
D2 symmetric homotetramer. The 24-residue
helix bundle contains two bis-histidine binding
sites that accommodate two nonbiological
iron diphenylporphyrin cofactors (FeIIIDPP),
which are poised to form a multicentered
pathway for transmembrane electron transfer
(Figure 3). Using threonine residues, an interhel-
ical second-shell hydrogen bond was designed
to stabilize and orient the metal-coordinating
histidine residues (Cochran et al., 2005; Kore-
ndovych et al., 2010). The stability of the
complex derives from complementary van der
Waals interactions throughout the interior, de-signed bis-his cofactor coordination, and His-Thr hydrogen
bonding between helices (Cochran et al., 2005; Korendovych
et al., 2010). The energies for the designed membrane protein
were scored using the CHARMM potential with an implicit
membrane solvation model (Lazaridis, 2003). The suitability of
the sequence was assessed from calculations using a statistical
potential (EZ) based upon the observed positioning of amino
acids within the lipid bilayer (Senes et al., 2007). The designed
membrane protein PRIME displays specificity for the FeIIIDPP
cofactor and has the expected stoichiometry. The CD spectra
are consistent with the targeted helical structure and orientation
of the cofactors. The measured reduction potentials (E1/2) are
consistent with the target structure, and the difference in E1/2
for reduction of the first and second FeIIIDPP is similar to that
measured for natural four-helix/bis-Fe-porphyrin proteins. This
study establishes that guiding principles used for the design of
soluble proteins, e.g., complementary van der Waals interac-
tions and metal ion coordination, can be augmented to include
features specific to membrane proteins to arrive at designed
transmembrane complexes containing nonbiological redox-
active cofactors.
Computational design has been used to examine the role of
cooperative interactions between residues in a serine-zipper
transmembrane helix motif. A probabilistic method was used
to partially design sequences for a pair of associating helices.
The designed protein forms a parallel helix dimer, but mutation
of the central serine residues to alanines yields dimers of com-
parable stability, suggesting that complementary van der Waals
interactions, rather than hydrogen bonding, play a dominant role
in stabilizing the dimer (North et al., 2006).11, 2012 ª2012 Elsevier Ltd All rights reserved 9
Figure 4. CHAMP Transmembrane Peptides
Structural models of the CHAMP transmembrane
peptides (blue) designed to bind aIIb (right) and av (left)
integrins (yellow) with high specificity; both trans-
membrane motifs naturally bind integrin b3 (Yin et al.,
2007). The GxxxG motif is highlighted with space-filling
representations in both cases.Leveraging the expertise gained from studying transmem-
brane proteins, it is possible to design transmembrane proteins
that modulate the activities of the natural ones. Helical peptides
have been designed that associate with the transmembrane
domains of integrins and modulate their functions using
a computational method, computed helical anti membrane
protein (CHAMP) (Yin et al., 2007). The native activity of the
human integrins aIIbb3 and avb3 is modulated by association of
the helical transmembrane domains of the a and b subunits.
Together with interaction of their cytoplasmic domains, the
interaction of the transmembrane helices stabilizes the inactive
state, whereas stimulation by an agonist such as adenosine
50-diphosphate (ADP) shifts the integrin to an active state. The
interaction of the transmembrane domains of the integrin aIIbb3
with a peptide from the transmembrane domain of aIIb (aIIb–
TM) induces platelet aggregation and yields dissociation of the
a and b heterodimer (Yin et al., 2006). This information was
used to guide the identification of peptides that selectively
recognize the transmembrane domains of aIIb and av (Yin et al.,
2007). The sequence of the target transmembrane domains
of aIIb and av were compared to existing structural motifs.
A suitable backbone geometry was identified from a library of
structurally defined helix pairs that were already local minima
with respect to interhelical backbone-backbone interactions.
This transmembrane structure and sequence of aIIb on one
(integrin) helix provided a ‘‘mold’’ for design of a second helix,
the CHAMP peptide. Complementary van derWaals interactions
were obtained by designing the sequence using a Monte Carlo10 Structure 20, January 11, 2012 ª2012 Elsevier Ltd All rights reservedalgorithm. The calculations used energies
derived from van der Waals interactions and
a statistical potential for transmembrane orien-
tation (EZ potential (Senes et al., 2007)). The
residues residing in the lipid interior were
restrained to the amino acids most frequently
found in transmembrane helices (G, A, V, I, L,
S, T, and F). The resulting anti-aIIb and anti-av
peptides (Figure 4) recognized their targets
with high specificity and formed heterodimers
in micelles. Moreover, the anti-aIIb and anti-av
peptides strongly activated aIIbb3 and avb3 in
mammalian cells, resulting in platelet aggrega-
tion (aIIbb3) or adhesion (avb3). Despite the simi-
larity of these integrins and of the templates
used, cross-reactivity of the designed peptides
was not observed. Finally, the roles of the
GxxxG-like motif (Russ and Engelman, 2000),
complementary van der Waals interactions,
and the Ca-H hydrogen bonding with a carbonyl
group (Senes et al., 2001) were suggested as
major driving forces in the selective associationof the transmembrane helices. The approach has been further
validated in studies of the direct interaction of the designed
anti-aIIb CHAMP peptide with isolated full-length integrin aIIbb3
in detergent micelles. The designed peptides assume a-helical
conformations that span the membrane and do not disrupt the
bilayer integrity (Caputo et al., 2008).
The structure determination and functional characterization of
membrane proteins remain challenging. Much of the difficulty
arises from the poor expression level and poor solubility of the
typical membrane protein. As a result, a variety of cell-free,
prokaryotic, and eukaryotic overexpression systems are
commonly employed to generate proteins in sufficiently large
amounts, and then surfactants or coproteins are employed to
disperse and, when possible, crystallize the protein. Such efforts
to realize large quantities of a membrane protein in a form suit-
able for structural studies are time-intensive and often involve
extensive trial and error.
An alternative approach is to redesign a membrane protein as
a water-soluble variant while retaining the overall structure and
many of the functionally related properties, e.g., ligand binding.
Soluble proteins are usually much easier to obtain in large
quantity, purify, and analyze structurally. Transmembrane pro-
teins have large numbers of exterior hydrophobic residues
that complement the hydrophobic character of the bilayer inte-
rior. For many membrane proteins, the interior of the protein
structure is similar to that of a typical water-soluble protein in
that it has large numbers of complementary hydrophobic resi-
dues. The solubilization approach focuses on redesigning the
Figure 5. Transmembrane Portion of the
Bacterial Potassium Ion Channel KcsA and
its Water-Soluble Variant
Comparison of the structure of the bacterial
potassium ion channel KcsA (yellow) (PDB
accession code: 1K4C) (Zhou et al., 2001) and its
water-soluble variant (blue) (PDB accession code:
2K1E) (Ma et al., 2008). The water-soluble variant
was expressed in E. Coli and contains 29
computationally designed exterior mutations in
each of the four 104-residue subunits. Depicted as
orange spheres in the water-soluble structure
(blue) are the Ca atoms for the exterior positions
that were computationally designed (Slovic et al.,
2004). In the right image, all four subunits are de-
picted, whereas in the left image (side view), only
two subunits are rendered.hydrophobic exterior transmembrane positions of the protein.
Using computational design, water-soluble variants of trans-
membrane proteins have been designed, providing a proof of
principle for the creation of variants that facilitate structural
and functional studies (Bronson et al., 2006; Slovic et al.,
2004). An initial target was the bacterial potassium ion channel
KcsA, specifically the tetrameric integral membrane region
(Zhou et al., 2001). The computationally designed water-soluble
variant contains 29 designed exterior mutations in each of the
four 104-residue subunits of the transmembrane domain. The
protein was redesigned using a probabilistic design method so
as to have exterior residues in the transmembrane domain that
are consistent with each other and with those expected on the
surface of a water-soluble protein (Slovic et al., 2004). The site-
dependent probabilities of the amino acids at variable exterior
positions were determined using a molecular potential (Amber)
and an environmental energy (solvation propensity) for the amino
acids that were tuned to values consistent with those observed
among soluble proteins of similar size. The designed proteins
express in large yield in E. coli, and one designed variant forms
predominantly the target tetramer in solution. This protein
(WSK-3) binds an ion channel toxin with the stoichiometry and
affinity of the wild-type protein. The solution structure of
WSK-3 has been determined using NMR methods (Ma et al.,
2008). The tertiary and quaternary structures are in excellent
agreement with those from the X-ray crystallographic structure
of the membrane-soluble wild-type protein (Figure 5) (Ma et al.,
2008; Zhou et al., 2001). As expected, the water-soluble form
exhibits larger structural fluctuations than does the membrane-
bound form (Bronson et al., 2006; Ma et al., 2008). The chemical
shifts of the residues bordering the selectivity filter of the protein
are highly sensitive to potassium ion concentration, consistent
with their native functional significance. The study suggests
that identification of water-soluble variants of membrane
proteins for biophysical, functional, and structural studies may
be achieved via the computational redesign of the sequence.
A similar solubilization approach was applied to obtain water-
soluble variants of the transmembrane domain of the a1 subunit
from a nicotinic acetylcholine receptor (nAChR), a eukaryotic
pentameric ligand-gated ion channel (Figure 6) (Cui et al.,
2012). Using the transmembrane domain of the a1 subunitStrucfrom the cryo-EM structure from Torpedo nAChR as a template
(Miyazawa et al., 2003), 23 exposed hydrophobic residues were
computationally redesigned. To express the designed protein as
a single chain, a polyglycine linker was used to connect the TM4
helix with a fragment containing the other three helices. The de-
signed sequence (WSA) was expressed in E. coli, and its NMR
structure was determined. The structure of WSA displays the ex-
pected four-helix bundle topology, but a detailed structural
comparison indicates that the WSA structure resembles more
the structure seen in GLIC, a prokaryotic homolog, than that in
the original template structure. This was somewhat surprising,
since the sequence ofWSA ismore similar to thewild-type trans-
membrane domain of nAChR (83%) than to the transmem-
brane domain of GLIC (11%). In addition, anesthetic binding
studies in WSA showed excellent agreement with the binding
site identified in the recent co-crystal structures of GLIC with
similar general anesthetics (Nury et al., 2011). This result indi-
cates that the designedwater-soluble analogs retain the putative
binding sites and thus could serve as good surrogates of
membrane proteins for drug screening. Also, to disperse WSA
at pH values suitable for NMR studies, 2% of LPPG detergent
was utilized. Based on intermolecular NMR crosspeaks, WSA-
detergent interactions were identified and compared with the
positions of lipid molecules present in the GLIC structure (Boc-
quet et al., 2009; Hilf and Dutzler, 2009). The location of the
interaction site of WSA-LPPG is in excellent agreement with
the location of the lipid in GLIC. These findings further support
the notion that the designed water-soluble variants are able to
retain important features of the structure, function, and intermo-
lecular interactions of their parent wild-type membrane proteins.
Application of computational approaches in membrane
protein design has established flexible, formal, and physically
grounded protocols to address the subtle interactions present
in membrane proteins while exploring new functionalities such
as the regulation of integrin activity. The examples described in
this section exemplify the power and tunability of computational
approaches. In addition, the strategy involving membrane
protein solubilization by redesign is supported by the two
successful studies; these findings point to the potential of
using this approach to obtain proteins in large quantity in forms
suitable for biophysical, ligand-binding, and structural studies.ture 20, January 11, 2012 ª2012 Elsevier Ltd All rights reserved 11
Figure 6. Cryo-EM Structure of
a Transmembrane Domain from the
Nicotinic Acetylcholine Receptor, NMR
Structure of Its Water-Soluble Analog, and
X-Ray Structure of the ProkaryoticHomolog
GLIC
Comparison of the 4-A˚-resolution cryo-EM struc-
ture of the transmembrane domain of the a1
subunit from the nicotinic acetylcholine receptor
(gray) (PDB accession code: 1OED) (Miyazawa
et al., 2003), the NMR structure of a water-soluble
analog (WSA) from the same segment (blue)
(PDB accession code: 2LKG) (Cui et al., 2012),
and transmembrane domain of the prokaryotic
homolog GLIC (yellow) (PDB accession code:
3EAM) (Bocquet et al., 2009). The water-soluble
variant was expressed in E. Coli and contains 23
computationally designed exterior mutations (Ca
atoms of these positions are depicted as orange
spheres). To link the TM4 helix with the rest of
the bundle, a polyglycine linker was inserted
(magenta). Based on photoaffinity labeling
studies, V31 (green) was identified as a potential
binding site in WSA for general anesthetics (azi-
propofol and azi-isoflorane). For comparison, the
residues forming the anesthetic binding site in the
cocrystal structure of GLIC (Nury et al., 2011) are
shown in stick representation.Conclusions
Membrane protein design provides new routes to explore the
structures and functions of these important but recalcitrant
proteins, particularly when such design efforts are assisted by
computational methods. Design can provide routes to novel
proteins that can introduce new functions to membranes and
modulate their integrity. Designed proteins can be conduits for
transmembrane flow of ions, electrons, small molecules and (in
the case of signaling) information. Furthermore, designed
proteins can also be used to modulate the functional properties
of membrane-associated proteins, as in the case of transmem-
brane helical peptides targeted to the transmembrane domains
of specific integrins. Some of the long-standing problem areas
in structural biology are the difficulties associated with structural
and functional studies of membrane proteins from a molecular
perspective. The redesign of natural membrane proteins to facil-
itate their study—including removing them from the membrane
altogether in the form of water-soluble proteins—provides
a promising route to obtain protein in large quantities and explore
functions and structures. Such studies have obvious relevance
to drug development. Computationally guided protein design
stands to make studies of membrane proteins more informative
and effective. The design of proteins that have the complexity,
efficiency, and specificity of nature’s proteins is likely to remain
challenging, but combining computational design and experi-
mental studies will advance our abilities to engineer novel
proteins, control biological activity, and better understand the
natural systems. Incorporating nonnatural functions and compo-
nents, e.g., nonbiological amino acids and cofactors, will yield
protein-based systems that have properties not available in
nature. Perhaps most important, attempts to design novel
membrane proteins will provide stringent assessments of our
understanding of the important structural, energetic, and func-
tional features of these vital molecular systems.12 Structure 20, January 11, 2012 ª2012 Elsevier Ltd All rights reservACKNOWLEDGMENTS
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